4//SEC Filing
Brenner Randall B. 4
Accession 0000904454-21-000516
CIK 0001178711other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:30 PM ET
Size
7.0 KB
Accession
0000904454-21-000516
Insider Transaction Report
Form 4
Brenner Randall B.
Chief Development & Regulatory
Transactions
- Award
Common Stock
2021-05-27+28,636→ 278,918 total - Sale
Common Stock
2021-06-04$9.70/sh−9,978$96,787→ 268,940 total
Footnotes (3)
- [F1]Represents performance-based restricted stock units ("PRSUs") granted on February 19, 2020 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on May 27, 2021.
- [F2]Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.58 to $9.97. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001788249
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:30 PM ET
- Size
- 7.0 KB